65
Participants
Start Date
March 9, 2022
Primary Completion Date
December 15, 2024
Study Completion Date
December 20, 2024
Ambroxol Hydrochloride
Drug Ambroxol hydrochloride 200 mg plus excipients. The manufacturing process of the 200 mg Ambroxol hydrochloride tablets will be performed by wet granulation, drying, mixing and compression to the target final weight.
Placebo
Excipients
Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan
"IRCCS National Neurological Institute C. Mondino Foundation", Pavia
"University of Campania Luigi Vanvitelli", Naples
"IRCCS National Neurological Institute C. Mondino Foundation"
OTHER
University of Campania Luigi Vanvitelli
OTHER
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
OTHER